An international expert Delphi consensus on defining textbook outcome in liver surgery (TOLS)

…, M D'Hondt, I Dagher, C Dervenis, J Devar… - Annals of …, 2023 - journals.lww.com
Objective: To reach global expert consensus on the definition of TOLS in minimally invasive
and open liver resection among renowned international expert liver surgeons using a …

Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA …

…, T Gruenberger, E Jonas, J Devar… - British journal of …, 2023 - academic.oup.com
Background Contemporary management of patients with synchronous colorectal cancer and
liver metastases is complex. The aim of this project was to provide a practical framework for …

Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy

D Kruger, YY Yako, J Devar, N Lahoud, M Smith - PloS one, 2019 - journals.plos.org
Background Early diagnosis of pancreatic ductal adenocarcinoma (PDAC) is challenged by
the absence of accurate early diagnostic and prognostic biomarkers. CA19-9 is the …

[HTML][HTML] Targeting growth factor signaling pathways in pancreatic cancer: towards inhibiting chemoresistance

N Xelwa, GP Candy, J Devar, J Omoshoro-Jones… - Frontiers in …, 2021 - frontiersin.org
Pancreatic cancer is one of the most deadly cancers, ranking amongst the top leading
cause of cancer related deaths in developed countries. Features such as dense stroma …

Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects

Z Nsingwane, G Candy, J Devar… - Molecular Biology …, 2020 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest human malignancies with
a dismal prognosis. During PDAC progression, the immune response is affected as cancer …

SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular …

EE Nweke, P Naicker, S Aron, S Stoychev, J Devar… - PLoS …, 2020 - journals.plos.org
Pancreatic cancer accounts for 2.8% of new cancer cases worldwide and is projected to
become the second leading cause of cancer-related deaths by 2030. Patients of African …

Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry

…, TN Augustine, M Smith, G Candy, J Devar… - Clinical Proteomics, 2023 - Springer
Background Gallbladder cancer (GBC) is a lethal cancer with a poor prognosis. The lack of
specific and sensitive biomarkers results in delayed diagnosis with most patients presenting …

Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease

D Kruger, N Lahoud, YY Yako, J Devar, M Smith - PLoS One, 2022 - journals.plos.org
Background/Objectives Pancreatic ductal adenocarcinoma (PDAC) is an aggressive
malignancy associated with high metastatic risk. Prognosis remains poor even after resection. …

Serum metabolomic and lipoprotein profiling of pancreatic ductal adenocarcinoma patients of african ancestry

N Elebo, J Omoshoro-Jones, PN Fru, J Devar… - Metabolites, 2021 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a characteristic dysregulated
metabolism. Abnormal clinicopathological features linked to defective metabolic and …

Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS)

…, M Adham, R Andersson, M Del Chiaro, J Devar… - Surgery, 2020 - Elsevier
Background The International Study Group for Pancreatic Surgery provides globally accepted
definitions for reporting of complications after pancreatic surgery. This International Study …